Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Buy
663
+23
+4% +$7.87K 0.21% 117
2026
Q1
$225K Sell
640
-180
-22% -$64.2K 0.22% 111
2025
Q4
$268K Buy
+820
New +$260K 0.27% 91

Other funds holding AMGN

J.M. Arbour's AMGN Position: Q2 2026 in Review

J.M. Arbour increased its Amgen (AMGN) stake by 3.6% in Q2 2026, buying an estimated $7.87K and bringing the position to 663 shares worth $240K. The position accounts for 0.21% of the portfolio, ranked #117.

J.M. Arbour first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $268K in Q4 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • J.M. Arbour held 663 shares of Amgen worth $240K as of Q2 2026.
  • J.M. Arbour bought 23 Amgen shares in Q2 2026, an estimated $7.87K.
  • Amgen made up 0.21% of J.M. Arbour's portfolio in Q2 2026, its #117 holding.
  • J.M. Arbour first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • J.M. Arbour's Amgen position peaked at $268K in Q4 2025.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on J.M. Arbour's 13F filing for Q2 2026, filed 14 Aug 2026.